Charles J. Siegel, M.D.

ASTEPRO 0.15% (azelastine HCl) Has Your Patients Covered

Compared with selected prescription antihistamines ASTEPRO 0.15% offers the highest Tier 2 availability under commercial managed care plans*

National formulary coverage for commercial plans

Patanase is a registered trademark of Alcon, Inc. Clarinex is a registered trademark of the Schering Corporation.

* Data on file. Meda Pharmaceuticals Inc; June, 2011. Percentage based upon formulary coverage under commercial managed care organizations.

^† For eligible, insured patients only. Coupon covers the balance of the copay over $25 (if any) for the first unit dispensed and for refills. Maximum value of $100 per dispensed unit. Offer expires 12/31/2012. Please see full program terms and conditions on the back of the Instant Savings Card brochure or visit www.ASTEPRO.com.

Indication for ASTEPRO^® 0.15%

ASTEPRO^® (azelastine HCl) Nasal Spray 0.15% is indicated for the relief of the symptoms of seasonal and perennial allergic rhinitis in patients 12 years of age and older.

Important Risk Information

Avoid engaging in hazardous occupations requiring complete mental alertness when taking ASTEPRO Nasal Spray 0.15%
Avoid concurrent use of alcohol or other central nervous system depressants with ASTEPRO Nasal Spray 0.15%
In clinical studies, the most commonly reported adverse reactions, when dosed at 2 sprays per nostril once or twice daily, respectively, included bitter taste (4%, 6%), nasal discomfort (4%, 3%), epistaxis (2%, 1%), and sneezing (1%, 2%)
Pregnancy Category C: Based on animal data, may cause fetal harm